Clinical Trial Update: The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the effects of bosentan on arterial stiffness in patients with systemic sclerosis (scleroderma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleroderma
• Systemic Sclerosis

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Scleroderma, Systemic | Phase 4 | Status: COMPLETED